Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes

Diabetologia

Volumn 59, Issue 3, 2016, Pages 560-570

  Acosta, Juan R ^a   Douagi, Iyadh ^a   Andersson, Daniel P ^a   Bäckdahl, Jesper ^a   Rydén, Mikael ^a   Arner, Peter ^a   Laurencikiene, Jurga ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adipocyte hypertrophy; Non obese; Subcutaneous adipose; Type 2 diabetes

Indexed keywords

INSULIN; TUMOR NECROSIS FACTOR;

ADIPOCYTE; ADULT; AGED; CASE CONTROL STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; LIPOLYSIS; MACROPHAGE; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOLOGY; PHYSIOLOGY; SUBCUTANEOUS FAT; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE, WHITE; ADULT; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOLYSIS; MACROPHAGES; MALE; MIDDLE AGED; OBESITY; SUBCUTANEOUS FAT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84957432759     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3810-6     Document Type: Article

References (48)

1. DeFuria J, Belkina AC, Jagannathan-Bogdan M et al (2013) B cells promote inflammation in obesity and type 2 diabetes through regulation of T cell function and an inflammatory cytokine profile. Proc Natl Acad Sci U S A 110:5133–5138
2. Stefanovic-Racic M, Yang X, Turner MS et al (2012) Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases in CD11c+ cells in adipose tissue and liver. Diabetes 61:2330–2339
3. Weisberg SP, McCann D, Desai M et al (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796–1808
4. Wentworth JM, Naselli G, Brown WA et al (2010) Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 59:1648–1656
5. Lee BC, Lee J (2014) Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta 1842:446–462
6. O’Rourke RW, White AE, Metcalf MD et al (2011) Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cells. Diabetologia 54:1480–1490
7. Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85–97
8. Glass CK, Olefsky JM (2012) Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab 15:635–645
9. Arner E, Ryden M, Arner P (2010) Tumor necrosis factor alpha and regulation of adipose tissue. N Engl J Med 362:1151–1153
10. Weyer C, Foley JE, Bogardus C et al (2000) Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43:1498–1506
11. Lonn M, Mehlig K, Bengtsson C, Lissner L (2010) Adipocyte size predicts incidence of type 2 diabetes in women. FASEB J 24:326–331
12. Arner P, Arner E, Hammarstedt A, Smith U (2011) Genetic predisposition for type 2 diabetes, but not for overweight/obesity, is associated with a restricted adipogenesis. PLoS One 6, e18284
13. Rosengren AH, Braun M, Mahdi T et al (2012) Reduced insulin exocytosis in human pancreatic beta-cells with gene variants linked to type 2 diabetes. Diabetes 61:1726–1733
14. Barroso I, Gurnell M, Crowley VE et al (1999) Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402:880–883
15. Kozusko K, Tsang VH, Bottomley W et al (2015) Clinical and molecular characterization of a novel PLIN1 frameshift mutation identified in patients with familial partial lipodystrophy. Diabetes 64:299–310
16. Gustafson B, Hammarstedt A, Hedjazifar S, Smith U (2013) Restricted adipogenesis in hypertrophic obesity: the role of WISP2, WNT, and BMP4. Diabetes 62:2997–3004
17. Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
18. Kolaczynski JW, Morales LM, Moore JH Jr et al (1994) A new technique for biopsy of human abdominal fat under local anaesthesia with lidocaine. Int J Obes Relat Metab Disord 18:161–166
19. Hoffstedt J, Arner E, Wahrenberg H et al (2010) Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia 53:2496–2503
20. Rodbell M (1964) Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375–380
21. Eriksson-Hogling D, Andersson DP, Backdahl J et al (2015) Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss. Int J Obes (Lond) 39:893–898
22. Hirsch J, Gallian E (1968) Methods for the determination of adipose cell size in man and animals. J Lipid Res 12:91–95
23. van Harmelen V, Skurk T, Hauner H (2005) Primary culture and differentiation of human adipocyte precursor cells. Methods Mol Med 107:125–135
24. Arner E, Westermark PO, Spalding KL (2010) Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 59:105–109
25. Zeyda M, Farmer D, Todoric J et al (2007) Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (Lond) 31:1420–1428
26. Liu W, Putnam AL, Xu-Yu Z et al (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203:1701–1711
27. Andersson DP, Eriksson Hogling D, Thorell A et al (2014) Changes in subcutaneous fat cell volume and insulin sensitivity after weight loss. Diabetes Care 37:1831–1836
28. Ryden M, Andersson DP, Bergstrom IB, Arner P (2014) Adipose tissue and metabolic alterations: regional differences in fat cell size and number matter, but differently: a cross-sectional study. J Clin Endocrinol Metab 99:E1870–E1876
29. Henninger AM, Eliasson B, Jenndahl LE, Hammarstedt A (2014) Adipocyte hypertrophy, inflammation and fibrosis characterize subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes. PLoS One 9, e105262
30. Cotillard A, Poitou C, Torcivia A et al (2014) Adipocyte size threshold matters: link with risk of type 2 diabetes and improved insulin resistance after gastric bypass. J Clin Endocrinol Metab 99:E1466–E1470
31. Esser N, L’Homme L, de Roover A et al (2013) Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue. Diabetologia 56:2487–2497
32. Fujisaka S, Usui I, Bukhari A et al (2009) Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 58:2574–2582
33. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87–91
34. Xu H, Barnes GT, Yang Q et al (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821–1830
35. Travers RL, Motta AC, Betts JA et al (2014) The impact of adiposity on adipose tissue-resident lymphocyte activation in humans. Int J Obes (Lond) 39:762–769
36. van Beek L, Lips MA, Visser A et al (2014) Increased systemic and adipose tissue inflammation differentiates obese women with T2DM from obese women with normal glucose tolerance. Metabolism 63:492–501
37. Viardot A, Heilbronn LK, Samocha-Bonet D et al (2012) Obesity is associated with activated and insulin resistant immune cells. Diabetes Metab Res Rev 28:447–454
38. Feuerer M, Herrero L, Cipolletta D et al (2009) Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15:930–939
39. van der Weerd K, Dik WA, Schrijver B et al (2012) Morbidly obese human subjects have increased peripheral blood CD4+ T cells with skewing toward a Treg- and Th2-dominated phenotype. Diabetes 61:401–408
40. Hammarstedt A, Hedjazifar S, Jenndahl L et al (2013) WISP2 regulates preadipocyte commitment and PPARγ activation by BMP4. Proc Natl Acad Sci U S A 110:2563–2568
41. Gustafson B, Smith U (2012) The WNT inhibitor Dickkopf 1 and bone morphogenetic protein 4 rescue adipogenesis in hypertrophic obesity in humans. Diabetes 61:1217–1224
42. Hesslein DG, Fretz JA, Xi Y et al (2009) Ebf1-dependent control of the osteoblast and adipocyte lineages. Bone 44:537–546
43. Gao H, Mejhert N, Fretz JA et al (2014) Early B cell factor 1 regulates adipocyte morphology and lipolysis in white adipose tissue. Cell Metab 19:981–992
44. Hammarstedt A, Graham TE, Kahn BB (2012) Adipose tissue dysregulation and reduced insulin sensitivity in non-obese individuals with enlarged abdominal adipose cells. Diabetol Metab Syndr 4:42
45. Jernas M, Palming J, Sjoholm K et al (2006) Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J 20:1540–1542
46. Gogebakan O, Osterhoff MA, Schuler R et al (2015) GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial. Diabetologia 58:1759–1768
47. Grisouard J, Timper K, Bouillet E et al (2011) Metformin counters both lipolytic/inflammatory agents-decreased hormone sensitive lipase phosphorylation at Ser-554 and -induced lipolysis in human adipocytes. Arch Physiol Biochem 117:209–214
48. Flechtner-Mors M, Ditschuneit HH, Jenkinson CP et al (1999) Metformin inhibits catecholamine-stimulated lipolysis in obese, hyperinsulinemic, hypertensive subjects in subcutaneous adipose tissue: an in situ microdialysis study. Diabet Med 16:1000–1006